Our data identified a critical protective role for monocytic Grx1 in atherosclerosis and obesity and revealed a negative feedback mechanism between Grx1 activity and the expression of NADPH oxidases (NOX), nitric oxide synthases (NOS), and arginase 2 (ARG2). The gene discussed is GLRX; the disease is obesity disorder.